Plasticity of purine release during cerebral ischemia: Clinical implications?

Journal of Cellular and Molecular Medicine

Volumn 7, Issue 4, 2003, Pages 362-375

  Pearson, T ^a   Currie, Ailsa J ^a   Etherington, Lori An V ^a   Gadalla, Anne E ^a   Damian, Karen ^a   Llaudet, E ^b   Dale, N ^b   Frenguelli, Bruno G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Adenosine; ATP; Epilepsy; Glutamate; Hypoxia; Inosine; Ischemia; Nucleosides; Nucleotides; Purines; Purinoceptor; Seizure; TBI

Indexed keywords

MAMMALIA;

ADENOSINE; ADENOSINE RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; BRAIN HYPOXIA; BRAIN ISCHEMIA; EXTRACELLULAR FLUID; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; BRAIN ISCHEMIA; EXTRACELLULAR FLUID; HUMANS; HYPOXIA, BRAIN; MODELS, NEUROLOGICAL; RECEPTORS, PURINERGIC P1; SYNAPTIC TRANSMISSION;

EID: 1842853035     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2003.tb00239.x     Document Type: Review

References (100)

1. Porkka-Heiskanen, T., Adenosine in sleep and wakefulness, Ann. Med, 31: 125-129, 1999
2. Sawynok, J. Liu, X.J., Adenosine in the spinal cord and periphery: release and regulation of pain, Prog. Neurobiol., 69: 313-340, 2003
3. Brundege, J.M. Dunwiddie, T.V., Role of adenosine as a modulator of synaptic activity in the central nervous system, Adv. Pharmacol., 39: 353-391, 1997
4. Mubagwa, K. Flameng, W., Adenosine, adenosine receptors and myocardial protection: an updated overview, Cardiovasc. Res., 52: 25-39, 2001
5. Dale, N., Resetting intrinsic purinergic modulation of neural activity: an associative mechanism?, J. Neurosci., 22: 10461-10469, 2002
6. Ralevic, V. Burnstock, G., Receptors for purines and pyrimidines, Pharmacol. Rev., 50: 413-492, 1998
7. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N., Linden, J., International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol. Rev., 53: 527-552, 2001
8. Fredholm, B.B., Irenius, E., Kull, B., Schulte, G., Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells, Biochem. Pharmacol., 61: 443-448, 2001
9. 3 adenosine receptors and stimulates mast cell degranulation, J. Clin. Invest, 100: 2849-2857, 1997
10. Ribeiro, J.A., Sebastiao, A.M., de Mendonça, A., Adenosine receptors in the nervous system: pathophysiological implications, Prog. Neurobiol., 68: 377-392, 2002
11. Maia, L. de Mendonça, A., Does caffeine intake protect from Alzheimer's disease?, Enr. J. Neurol., 9: 377-382, 2002
12. 2A receptor antagonist istradefylline in advanced PD, Neurology, 61: 297-303, 2003
13. 2A receptor antagonist treatment of Parkinson's disease, Neurology, 61: 293-296, 2003
14. Blum, D., Hourez, R., Galas, M.C., Popoli, P., Schiffmann, S.N., Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics, Lancet Neurol., 2: 366-374, 2003
15. Weigand, M.A., Michel, A., Eckstein, H.H., Martin, E., Bardenheuer, H.J., Adenosine: a sensitive indicator of cerebral ischemia during carotid endarterectomy, Anesthesiology, 91: 414-421, 1999
16. Laghi-Pasini, F., Guideri, F., Picano, E., Parenti, G., Petersen, C., Varga, A., Di Perri, T., Increase in plasma adenosine during brain ischemia in man: a study during transient ischemic attacks, and stroke, Brain Res. Bull., 51: 327-330, 2000
17. Robertson, C.L., Bell, M.J., Kochanek, P.M., Adelson, P.D., Ruppel, R.A., Carcillo, J.A., Wisniewski, S.R., Mi, Z., Janesko, K.L., Clark, R.S., Marion, D.W., Graham, S.H., Jackson, E.K., Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity, Crit Care Med., 29: 2287-2293, 2001
18. Clark, R.S., Carcillo, J.A., Kochanek, P.M., Obrist, W.D., Jackson, E.K., Mi, Z., Wisneiwski, S.R., Bell, M.J., Marion, D.W., Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans, Neurosurgery, 41: 1284-1292, 1997
19. During, M.J. Spencer, D.D., Adenosine: a potential mediator of seizure arrest and postictal refractoriness, Ann. Neurol., 32: 618-624, 1992
20. Matsumoto K., Graf R., Rosner G., Shimada N., Heiss W.D., Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia, Brain Res., 579: 309-314, 1992
21. Haas, H.L. Selbach, O., Functions of neuronal adenosine receptors, Naunyn Schmiedebergs Arch. Pharmacol., 362: 375-381, 2000
22. 1 receptor activation, NeuroReport, 6: 1097-1100, 1995
23. de Mendonça, A., Sebastiao, A.M., Ribeiro, J.A., Adenosine: does it have a neuroprotective role after all?, Brain Res. Rev., 33: 258-274, 2000
24. 1 receptor, Proc. Natl. Acad. Sci. USA, 98: 9407-9412, 2001
25. Sweeney, M.I., Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity, Neurosci. Biobehav. Rev., 21: 207-217, 1997
26. 1 receptor agonist or antagonist in cerebral ischemia, Eur. J. Pharmacol., 256: 161-167, 1994
27. 3 receptors and cerebroprotection in stroke, Ann. NY Acad. Sci., 939: 85-96, 2001
28. Von Lubitz, D.K., Adenosine in the treatment of stroke: yes, maybe, or absolutely not?, Expert Opin. Investig. Drugs, 10: 619-632, 2001
29. 3 adenosine receptor: sensitivity to hypoxic neurodegeneration, Cell Mol. Neurobiol., 23: 431-447, 2003
30. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice, J. Neurosci., 19: 9192-9200, 1999
31. 2A knockout mice, Stroke, 34: 739-744, 2003
32. 1 receptor inhibition, Neuroscience, 112: 319-329, 2002
33. 1 receptor-mediated responses in rat hippocampus, J. Neurosci., 17: 607-614, 1997
34. 2A receptor facilitation of synaptic transmission in the hippocampus of aged rats, J. Neurophysiol., 90: 1295-1303, 2003
35. Frenguelli, B.G., Llaudet, E., Dale, N., High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices., J. Neurochem., 86: 1506-1515, 2003
36. Sebastiao, A.M. Ribeiro, J.A., Fine-tuning neuromodulation by adenosine, Trends Pharmacol. Sci., 21: 341-346, 2000
37. Dunwiddie, T.V. Masino, S.A., The role and regulation of adenosine in the central nervous system, Annu. Rev. Neurosci., 24: 31-55, 2001
38. Robertson, S.J., Ennion, S.J., Evans, R.J., Edwards, F.A., Synaptic P2X receptors, Curr. Opin. Neurobiol., 11: 378-386, 2001
39. Zimmermann, H., Extracellular metabolism of ATP and other nucleotides, Naunyn Schmiedebergs Arch. Pharmacol., 362: 299-309, 2000
40. Manzoni, O.J., Manabe, T., Nicoll, R.A., Release of adenosine by activation of NMDA receptors in the hippocampus, Science, 265: 2098-2101, 1994
41. Mitchell, J.B., Lupica, C.R., Dunwiddie, T.V., Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus, J. Neurosci., 13: 3439-3447, 1993
42. Brager, D.H. Thompson, S.M., Activity-dependent release of adenosine contributes to short-term depression at CA3-CA1 synapses in rat hippocampus, J. Neurophysiol., 89: 22-26, 2003
43. Harvey, J. Lacey, M.G., A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release, J. Neurosci., 17: 5271-5280, 1997
44. Hugel, S. Schlichter, R., Convergent control of synaptic GABA release from rat dorsal horn neurones by adenosine and GABA autoreceptors, J. Physiol. (Lond.), 2003
45. Dunwiddie, T.V., Adenosine and suppression of seizures, Adv. Neurol., 79: 1001-1010, 1999
46. Phillis, J.W., O'Regan, M.H., Perkins, L.M., Adenosine 5′-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex, Neurosci. Lett., 151: 94-96, 1993
47. Pedata, F., Latini, S., Pugliese, A.M., Pepeu, G., Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions, J. Neurochem., 61: 284-289, 1993
48. Dale, N., Pearson, T., Frenguelli, B.G., Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice, J. Physiol. (Lond.), 526: 143-155, 2000
49. Pearson, T., Frenguelli, B.G., Volume-regulated anion channels do not contribute extracellular adenosine during the hypoxic depression of excitatory synaptic transmission in area CA1 of rat hippocampus, Eur. J. Neurosci., 12: 3064-3066, 2000
50. Seki, Y., Feustel, P.J., Keller, R.W.J., Tranmer, B.I., Kimelberg, H.K., Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker, Stroke, 30: 433-440, 1999
51. Phillis, J.W., Song, D., O'Regan, M.H., Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex, Brain Res., 758: 9-16, 1997
52. Phillis, J.W., Song, D., O'Regan, M.H., Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex, Brain Res., 780: 352-355, 1998
53. [3H]aspartate release from primary astrocyte cultures, Am. J. Physiol., 274: C1511-C1520, 1998
54. Nelson, R.M., Lambert, D.G., Richard, G.A., Hainsworth, A.H., Pharmacology of ischemia-induced glutamate efflux from rat cerebral cortex in vitro, Brain Res., 964: 1-8, 2003
55. [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices, Brain Res., 823: 183-190, 1999
56. Parkinson, F.E., Sinclair, C.J., Othman, T., Haughey, N.J., Geiger, J.D., Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions, Neuropharmacol., 43: 836-846, 2002
57. Koos, B.J., Kruger, L., Murray, T.F., Source of extracellular brain adenosine during hypoxia in fetal sheep, Brain Res., 778: 439-442, 1997
58. Braun, N., Zhu, Y., Krieglstein, J., Culmsee, C., Zimmermann, H., Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat, J. Neurosci., 18: 4891-4900, 1998
59. Ryu, J.K., Kim, J., Choi, S.H., Oh, Y.J., Lee, Y.B., Kim, S.U., Jin, B.K., ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors, NeuroReport, 13: 1611-1615, 2002
60. Cavaliere, F., Florenzano, F., Amadio, S., Fusco, F.R., Viscomi, M.T., D'Ambrosi, N., Vacca, F., Sancesario, G., Bernardi, G., Molinari, M., Volonte, C., Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists, Neuroscience, 120: 85-98, 2003
61. Dux, E., Fastbom, J., Ungerstedt, U., Rudolphi, K., Fredholm, B.B., Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus, Brain Res., 516: 248-256, 1990
62. Valtysson, J., Persson, L., Hillered, L., Extracellular ischaemia markers in repeated global ischaemia and secondary hypoxaemia monitored by microdialysis in rat brain, Acta Neurochir. (Wien.), 140: 387-395, 1998
63. DiGeronimo, R.J., Gegg, C.A., Zuckerman, S.L., Adenosine depletion alters postictal hypoxic cerebral vasodilation in the newborn pig, Am. J. Physiol., 274: H1495-H1501, 1998
64. 1 receptor in hypoxic preconditioning, Biol. Signals Recept., 8: 275-280, 1999
65. Matsumoto, K., Graf, R., Rosner, G., Taguchi, J., Heiss, W.D., Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia, J. Cereb. Blood Flow Metab., 13: 586-594, 1993
66. Phillis, J.W., O'Regan, M.H., Estevez, A.Y., Song, D., VanderHeide, S.J., Cerebral energy metabolism during severe ischemia of varying duration and following reperfusion, J. Neurochem., 67: 1525-1531, 1996
67. Melani, A., Pantoni, L., Corsi, C., Bianchi, L., Monopoli, A., Bertorelli, R., Pepeu, G., Pedata, F., Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage, Stroke, 30: 2448-2454, 1999
68. Dale, N., Gourine, A.V., Llaudet, E., Bulmer, D., Thomas, T., Spyer, K.M., Rapid adenosine release in the nucleus tractus solitarii during defence response in rats: real-time measurement in vivo, J. Physiol. (Lond.), 544: 149-160, 2002
69. Pearson, T., Nuritova, F., Caldwell, D., Dale, N., Frenguelli, B.G., A depletable pool of adenosine in area CA1 of the rat hippocampus, J. Neurosci., 21: 2298-2307, 2001
70. Fowler, J.C., Adenosine antagonists delay hypoxia-induced depressions of neuronal activity in hippocampal brain slice, Brain Res., 490: 378-384, 1989
71. Gervitz, L.M., Lutherer, L.O., Davies, D.G., Pirch, J.H., Fowler, J.C., Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo, Am. J. Physiol. Regul. Integr. Comp. Physiol., 280: R639-R645, 2001
72. Kato, H., Kogure, K., Nakano, S., Neuronal damage following repeated brief ischemia in the gerbil, Brain Res., 479: 366-370, 1989
73. Kirino, T., Ischemic tolerance, J. Cereb. Blood Flow Metab., 22: 1283-1296, 2002
74. Jenkins, L.W., Moszynski, K., Lyeth, B.G., Lewelt, W., DeWitt, D.S., Allen, A., Dixon, C.E., Povlishock, J.T., Majewski, T.J., Clifton, G.L., Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury, Brain Res., 477: 211-224, 1989
75. Gerlach, E., Marko, P., Zimmer, H.G., Pechan, I., Trendelenburg, C., Different response of adenine nucleotide synthesis de novo in kidney and brain during aerobic recovery from anoxia and ischemia, Experientia, 27: 876-878, 1971
76. Barsotti, C., Ipata, P.L., Pathways for alpha-D-ribose utilization for nucleobase salvage and 5-fluorouracil activation in rat brain, Biochem. Pharmacol., 63: 117-122, 2002
77. Pauly, D.F., Pepine, C.J., D-Ribose as a supplement for cardiac energy metabolism, J. Cardiovasc. Pharmacol. Ther., 5: 249-258, 2000
78. Lipton, P., Ischemic cell death in brain neurons, Physiol. Rev., 79: 1431-1568, 1999
79. Kleihues, P., Kobayashi, K., Hossmann, K.A., Purine nucleotide metabolism in the cat brain after one hour of complete ischemia, J. Neurochem., 23: 417-425, 1974
80. Onodera, H., Iijima, K., Kogure, K., Mononucleotide metabolism in the rat brain after transient ischemia, J. Neurochem., 46: 1704-1710, 1986
81. Yager, J.Y., Brucklacher, R.M., Vannucci, R.C., Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats, Am. J. Physiol., 262: H672-H677, 1992
82. Siesjö, B.K., Wieloch, T., Cerebral metabolism in ischaemia: neurochemical basis for therapy, Br. J. Anaesth., 57: 47-62, 1985
83. Bell, M.J., Robertson, C.S., Kochanek, P.M., Goodman, J.C., Gopinath, S.P., Carcillo, J.A., Clark, R.S., Marion, D.W., Mi, Z., Jackson, E.K., Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury, Crit Care Med., 29: 399-404, 2001
84. Kuracka, L., Kalnovicova, T., Liska, B., Turcani, P., HPLC method for measurement of purine nucleotide degradation products in cerebrospinal fluid, Clin. Chem., 42: 756-760, 1996
85. Akdemir, H., Asik, Z., Pasaoglu, H., Karakucuk, I., Oktem, I.S., Koc, R.K., The effect of allopurinol on focal cerebral ischaemia: an experimental study in rabbits, Neurosurg. Rev., 24: 131-135, 2001
86. Hagberg, H., Andersson, P., Lacarewicz, J., Jacobson, I., Butcher, S., Sandberg, M., Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia, J. Neurochem., 49: 227-231, 1987
87. Chapman, A.G., Westerberg, E., Siesjö, B.K., The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery, J. Neurochem., 36: 179-189, 1981
88. Phillis, J.W., Walter, G.A., O'Regan, M.H., Stair, R.E., Increases in cerebral cortical pcrfusate adenosine and inosine concentrations during hypoxia and ischemia., J. Cereb. Blood Flow Metab., 7: 679-686, 1987
89. Phillis, J.W., Perkins, L.M., Smith-Barbour, M., O'Regan, M.H., Oxypurinol-enhanced postischemic recovery of the rat brain involves preservation of adenine nucleotides, J. Neurochem., 64: 2177-2184, 1995
90. Plaschke, K., Bardenheuer, H.J., Weigand, M.A., Martin, E., Hoyer, S., Increased ATP production during long-term brain ischemia in rats in the presence of propentofylline, Eur. J. Pharmacol., 349: 33-40, 1998
91. Oliveira, I.J., Molz, S., Souza, D.O., Tasca, C.I., Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia, Cell Mol. Neurobiol., 22: 335-344, 2002
92. Lee, K.S., Schubert, P., Emmert, H., Kreutzberg, G.W., Effect of adenosine versus adenine nucleotides on evoked potentials in a rat hippocampal slice preparation, Neurosci. Lett., 23: 309-314, 1981
93. Cunha, R.A., Correia-de-Sa, P., Sebastiao, A.M., Ribeiro, J.A., Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides, Br. J. Pharmacol., 119: 253-260, 1996
94. Lu, K.T. Gean, P.W., Masking of forskolin-induced long-term potentiation by adenosine accumulation in area CA1 of the rat hippocampus, Neuroscience, 88: 69-78, 1999
95. Moroni, F., Russi, P., Lombardi, G., Beni, M., Carla, V., Presence of kynurenic acid in the mammalian brain., J. Neurochem., 51: 177-180, 1988
96. Shepard, P.D., Joy, B., Clerkin, L., Schwarcz, R., Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat, Neuropsychopharmacology, 28: 1454-1462, 2003
97. Brundege, J.M., Diao, L., Proctor, W.R., Dunwiddie, T.V., The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus, Neuropharmacol., 36: 1201-1210, 1997
98. Dale, N., Delayed production of adenosine underlies temporal modulation of swimming in frog embryo, J. Physiol. (Lond.), 511: 265-272, 1998
99. Frenguelli, B.G., The effects of metabolic stress on glutamate receptor-mediated depolarisations in the in vitro rat hippocampal slice, Neuropharmacol., 36: 981-991, 1997
100. Gadalla A.E., Pearson, T., Currie A.J., Dale N., Hawley S.A., Sheehan M., Hirst W., Michel A.D., Randall A., Hardie D.G., Frenguelli B.G., AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus, J. Neurochem (in Press), 2004